Insider trade

Onemednet (ONMD)CEO sold ~$145K

Aaron Green, CEO at Onemednet, sold ~$145K of Onemednet shares.

~$145K
Approx. value · 65K sh @ $2.23
1.87M
Holds after · shares reported
Traded
Oct 22, 2025
Filed
Dec 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 12, 2024InsiderDirector purchased ~$425 of ONMD shares in the open market
  2. Nov 20, 2024InsiderDirector purchased ~$1.1K of ONMD shares in the open market
  3. Dec 18, 2024InsiderDirector purchased ~$99 of ONMD shares in the open market
  4. Apr 21, 2025Insider · Their first buy on recordDirector purchased ~$23K of ONMD shares in the open market
  5. Jun 16, 2025InsiderDirector purchased ~$21K of ONMD shares in the open market
  6. Jun 20, 2025Insider · 2 peopleInsiders: 2 purchases (~$1.2M)
  7. Aug 19, 2025InsiderDirector purchased ~$13K of ONMD shares in the open market
  8. Aug 21, 2025InsiderDirector purchased ~$12K of ONMD shares in the open market
  9. Aug 25, 2025InsiderDirector purchased ~$10K of ONMD shares in the open market
  10. Aug 26, 2025InsiderDirector purchased ~$120K of ONMD shares in the open market
  11. Aug 27, 2025InsiderDirector purchased ~$15K of ONMD shares in the open market
  12. Aug 28, 2025InsiderDirector purchased ~$14K of ONMD shares in the open market
  13. Aug 29, 2025Insider · 2 peopleInsiders: 2 purchases (~$509K)
  14. Sep 2, 2025InsiderDirector purchased ~$21K of ONMD shares in the open market
  15. Sep 3, 2025InsiderDirector purchased ~$9.5K of ONMD shares in the open market
  16. Sep 4, 2025InsiderDirector purchased ~$10K of ONMD shares in the open market
  17. Sep 5, 2025InsiderDirector purchased ~$1.8K of ONMD shares in the open market
  18. Sep 18, 2025InsiderDirector purchased ~$637 of ONMD shares in the open market
  19. Sep 19, 2025InsiderDirector purchased ~$1.1K of ONMD shares in the open market
  20. Sep 22, 2025InsiderDirector purchased ~$380 of ONMD shares in the open market
  21. Sep 23, 2025InsiderDirector purchased ~$5.3K of ONMD shares in the open market
  22. Sep 24, 2025Insider · 2 peopleInsiders: 2 purchases (~$23K)
  23. Sep 25, 2025InsiderDirector purchased ~$1.3K of ONMD shares in the open market
  24. Oct 15, 2025Insider · Their largest buy since 2024Director purchased ~$31K of ONMD shares in the open market
  25. Oct 22, 2025 · this disclosureInsiderCEO sold ~$145K of ONMD shares in the open market

What came next

  1. Nov 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 6, 2025, Jair Clarke informed the Board of Directors (the “Board”) of OneMedNet Corporation (the “Company”) that he will not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).”
  2. Nov 18, 2025InsiderCEO sold ~$74K of ONMD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Onemednet

For Onemednet, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONMD page.

Other recent filings by Aaron Green, Chief Executive Officer

The full history of Aaron Green, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Onemednet

Everything OQRO holds on this company is on its ONMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data